1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Polyps Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Treatment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Pipeline Analysis
5.3. Qualitative Assessment on Novel Treatment Options for Nasal Polyps: Biologics & Stents
5.3.1. Key Insights on Biologics (Xolair, Dupixent, Nucala)
6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment
6.1. Introduction & Definition
6.2. Market Value Forecast, by Type of Treatment , 2017–2027
6.2.1. Pharmacological Therapies
6.2.1.1. Corticosteroids
6.2.1.2. Antibiotics
6.2.1.3. Leukotriene Inhibitors
6.2.1.4. Others
6.2.2. Surgeries
6.2.2.1. Polypectomy
6.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
6.3. Market Attractiveness By Type of Treatment
7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Market Value Forecast, by End-user, 2017–2027
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers
7.2.3. Specialty Clinics
7.3. Market Attractiveness, by End-user
8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region
8.1. Introduction
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Nasal Polyps Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast, by Type of Treatment , 2017–2027
9.2.1. Pharmacological Therapies
9.2.1.1. Corticosteroids
9.2.1.2. Antibiotics
9.2.1.3. Leukotriene Inhibitors
9.2.1.4. Others
9.2.2. Surgeries
9.2.2.1. Polypectomy
9.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Value Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type of Treatment
9.5.2. By End-user
9.5.3. By Country
10. Europe Nasal Polyps Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Type of Treatment , 2017–2027
10.2.1. Pharmacological Therapies
10.2.1.1. Corticosteroids
10.2.1.2. Antibiotics
10.2.1.3. Leukotriene Inhibitors
10.2.1.4. Others
10.2.2. Surgeries
10.2.2.1. Polypectomy
10.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
10.3. Market Value Forecast, by End-user, 2017–2027
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Specialty Clinics
10.4. Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type of Treatment
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Type of Treatment, 2017–2027
11.2.1. Pharmacological Therapies
11.2.1.1. Corticosteroids
11.2.1.2. Antibiotics
11.2.1.3. Leukotriene Inhibitors
11.2.1.4. Others
11.2.2. Surgeries
11.2.2.1. Polypectomy
11.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
11.3. Market Value Forecast, by End-user, 2017–2027
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Specialty Clinics
11.4. Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type of Treatment
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Nasal Polyps Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Type of Treatment, 2017–2027
12.2.1. Pharmacological Therapies
12.2.1.1. Corticosteroids
12.2.1.2. Antibiotics
12.2.1.3. Leukotriene Inhibitors
12.2.1.4. Others
12.2.2. Surgeries
12.2.2.1. Polypectomy
12.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
12.3. Market Value Forecast, by End-user, 2017–2027
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Specialty Clinics
12.4. Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type of Treatment
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Type of Treatment , 2017–2027
13.2.1. Pharmacological Therapies
13.2.1.1. Corticosteroids
13.2.1.2. Antibiotics
13.2.1.3. Leukotriene Inhibitors
13.2.1.4. Others
13.2.2. Surgery
13.2.2.1. Polypectomy
13.2.2.2. Functional Endoscopic Sinus Surgery (FESS)
13.3. Market Value Forecast, by End-user, 2017–2027
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Specialty Clinics
13.4. Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Type of Treatment
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Global Nasal Polyps Treatment Market Position Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. OptiNose US, Inc.
14.3.2. Regeneron Pharmaceuticals, Inc.
14.3.3. Merck & Co., Inc.
14.3.4. Pfizer, Inc.
14.3.5. F. Hoffmann La-Roche, Ltd.
14.3.6. Intersect ENT, Inc.
14.3.7. GlaxoSmithKline plc
14.3.8. Sanofi
14.3.9. Novartis AG
List of Tables
Table 01: Pipeline Analysis: Nasal Polyps
Table 02: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 04: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 05: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 09: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 10: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 11: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 12: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 14: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 15: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 16: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 17: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 19: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 20: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 21: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 22: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 24: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 25: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 26: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 27: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 29: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 30: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 31: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
List of Figures
Figure 01: Global Nasal Polyps Treatment Market Snapshot
Figure 02: Global Nasal Polyps Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
Figure 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 04: Global Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018
Figure 05: Global Nasal Polyps Treatment Market Value Share (%), by End-user, 2018
Figure 06: Global Nasal Polyps Treatment Market Value Share (%), by Region, 2018
Figure 07: Nasal Polyps Treatment Market - Collaborations, Partnerships & New Product Launch
Figure 08: Global Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 09: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmacological Therapies, 2017–2027
Figure 10: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Surgeries, 2017–2027
Figure 11: Global Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 12: Global Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 13: Global Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 14: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 15: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 16: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027
Figure 17: Global Nasal Polyps Treatment Market Value Share Analysis, by Region, 2018 and 2027
Figure 18: Global Nasal Polyps Treatment Market Attractiveness Analysis, by Region, 2019–2027
Figure 19: North America Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 20: North America Nasal Polyps Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 21: North America Nasal Polyps Treatment Market Attractiveness Analysis, by Country, 2019–2027
Figure 22: North America Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 23: North America Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 24: North America Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 25: North America Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 26: Europe Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 27: Europe Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 28: Europe Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 29: Europe Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 30: Europe Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 31: Europe Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 32: Europe Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 33: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 34: Asia Pacific Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 35: Asia Pacific Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 36: Asia Pacific Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 37: Asia Pacific Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 38: Asia Pacific Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 39: Asia Pacific Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 40: Latin America Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 41: Latin America Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42: Latin America Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 43: Latin America Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 44: Latin America Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 45: Latin America Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 46: Latin America Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 47: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 48: Middle East & Africa Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 49: Middle East & Africa Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 50: Middle East & Africa Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 51: Middle East & Africa Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 52: Middle East & Africa Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 53: Middle East & Africa Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 54: Global Nasal Polyps Treatment Market Position Analysis, by Top Company Ranking, 2018
Figure 55: OptiNose US, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 56: OptiNose US, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 57: Regeneron Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 58: Regeneron Pharmaceuticals, Inc. R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 59: Regeneron Pharmaceuticals Inc., Breakdown of Net Sales (%), by Product, 2018
Figure 60: Merck & Co., Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 61: Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 62: Merck & Co., Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 63: Merck & Co., Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 64: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 65: Pfizer, Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 66: Pfizer, Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 67: Pfizer, Inc., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 68: F. Hoffmann-La Roche, Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: F. Hoffmann-La Roche, Ltd., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 70: F. Hoffmann-La Roche, Ltd., Breakdown of Net Sales (%), by Region, 2018
Figure 71: F. Hoffmann-La Roche, Ltd., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 72: Intersect ENT, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Intersect ENT, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: GlaxoSmithKline plc, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 75: GlaxoSmithKline plc, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: GlaxoSmithKline plc, Breakdown of Net Sales (%), by Geography, 2018
Figure 77: GlaxoSmithKline plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 78: Sanofi, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 79: Sanofi, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 80: Sanofi, Breakdown of Net Sales (%), by Geography, 2018
Figure 81: Sanofi, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 82: Novartis AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 83: Novartis AG, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 84: Novartis AG, Breakdown of Net Sales (%), by Region, 2018
Figure 85: Novartis AG, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018